$18 million awarded to TGen and University of Pennsylvania for pancreatic cance... ( PHOENIX Ariz. May 27 2009 The Tran...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

$18 million awarded to TGen and University of Pennsylvania for pancreatic cancer research

Date:5/27/2009

PHOENIX, Ariz. May 27, 2009 The Translational Genomics Research Institute (TGen) and the University of Pennsylvania (Penn) will receive $18 million to research pancreatic cancer, Stand Up to Cancer (SU2C) announced today.

Dr. Daniel Von Hoff, TGen's Physician-In-Chief, and Dr. Craig B. Thompson, Director of the Abramson Cancer Center at Penn, are co-leaders of SU2C pancreatic cancer "Dream Team,'' which will lead a three-year investigation into new approaches to treating pancreatic cancer, the fourth leading cause of cancer death in the United States.

"We want to do something dramatic. It is going to take a tremendous amount of real thinking power to make that difference, so it is a dream come true to be able to put this team together to work towards this goal,'' said Dr. Von Hoff, who also is Chief Scientific Officer for TGen Clinical Research Services (TCRS) at Scottsdale Healthcare, a primary clinical research site for TGen and the SU2C grant.

The $18 million to TGen and Penn was the largest single grant among five awards, totaling $74 million, announced by SU2C, a philanthropic group created by cancer scientists and members of the entertainment industry a year ago today to quickly turn scientific discoveries into ways to care for cancer patients.

The goal of the pancreatic cancer Dream Team research project "Cutting Off the Fuel Supply'' is to develop tests, using advanced imaging techniques, to determine what nutrients pancreatic cancer cells require to fuel their growth and survival. Understanding the cell's fuel supply will help scientists develop more individualized treatments with fewer side effects.

TGen and its clinical partner at TCRS will launch a series of innovative clinical trials in advanced pancreatic cancer. These clinical trials will be designed to deprive pancreatic tumors of crucial nutrients, thereby cutting off the fuel supply.

TCRS is located at the Virginia G. Piper Cancer Cent
'/>"/>

Contact: Steve Yozwiak, TGen Senior Science Writer
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5
Related medicine news :

1. Hanger Orthopedic Group, Inc. Announces Two Acquisitions Totaling $5.3 Million of Annual Net Revenue
2. More Than 167,000 Fans Flock to Target Facebook Page Helping Donate $3 Million to Ten Charities
3. Ophthonix Completes Series AA Financing at $25.9 Million
4. Nearly 1 million Californians seek medical care in Mexico annually
5. Whole Foods Market(R) Lends $2.5 Million to Local Growers, Producers and Food Artisans
6. Schools and Cities Send 9.7 Million Messages During Swine Flu Outbreak with Blackboard Connect(TM) Platform
7. Cole Foundation injects $2.5 million to bolster leukemia research
8. N.J. Hospitals Face $97 Million in Medicare Cuts
9. Cephalon Announces Exercise of $65 Million Over-allotment Option on 2.50% Convertible Senior Subordinated Notes
10. Sensors for Medicine and Science, Inc. Completes $10 Million Financing
11. Secretary Shinseki Announces $215 Million in Projects for Rural Veterans

Post Your Comments:

(Date:3/7/2014)... had one glass of wine with dinner, but if you,re ... enough to make you a dangerous driver., So, baby boomers, ... used to. , Sara Jo Nixon, Ph.D., a professor in ... Florida and doctoral candidate Alfredo Sklar tested how drinking legally ... age groups: 36 people ages 25 to 35 and 36 ...

(Date:3/7/2014)... than 80 percent of raw chicken used in ... with a form of antibiotic resistant bacteria called extended-spectrum ... preparation eliminated the presence of bacteria, poultry meat delivered ... for these dangerous bacteria into the hospital. The study ... Control and Hospital Epidemiology , the journal of the ...

(Date:3/7/2014)... contact lens could possibly make life easier for some of ... sneezing and a runny nose as soon as the pollen ... a newly developed Danish mini-filter - Rhinix - appears to ... fever than a filterless placebo., The study has just been ... Immunology . , Filter blocks pollen , The filter, ...

(Date:3/7/2014)... Institute of Texas has awarded the University of Texas ... continue a program aimed at creating a new state ... treatments and outcomes in Texas. , One of 11 ... UTMB award will fund the work of the organization ... more years. , Led by Dr. James Goodwin, ...

(Date:3/6/2014)... A simple questionnaire that rates breathing difficulties on a ... graft-vs.-host disease, according to a study published in the ... Transplantation . , And although a poor score ... simple question that can spot lung involvement early means ... symptoms, said senior author Stephanie Lee, M.D., M.P.H., research ...

Breaking Medicine News(10 mins):Health News:For older drivers, study finds, 1 drink may be 1 too many 2 Health News:For older drivers, study finds, 1 drink may be 1 too many 3 Health News:Hospital food safety measures reduce risk of contaminated hospital food 2 Health News:Danish nasal filter looks promising for allergy sufferers 2 Health News:UTMB receives $3.2 million to continue collaborative research on cancer in Texas 2 Health News:Early detection helps manage a chronic graft-vs.-host disease complication 2

[0] For older drivers, study finds, 1 drink may be 1 too many [0] Hospital food safety measures reduce risk of contaminated hospital food [0] Danish nasal filter looks promising for allergy sufferers [0] UTMB receives $3.2 million to continue collaborative research on cancer in Texas [0] Early detection helps manage a chronic graft-vs.-host disease complication

... about to undergo pelvic radiotherapy or who have had the ... and embarrassing side effects, now have a new free resource ... ,The leading cancer charities have produced the two ... help the 12,000 patients in the UK who have pelvic ...

... Dolls and the Sugababes have come under flack from researchers ... a womans figure should look like, they are having a ... universities of Leeds and Sussex conducting a new study on ... skinny, found that watching such videos for only 10 minutes ...

... shown that a natural compound found in blueberries, tea, grapes, ... that its effects further increase when combined with regular exercise. ... epicatechin, one of a group of chemicals known as flavonols ... people and increase blood flow in the brain. ...

... development and spread of drug-resistant tuberculosis (TB), the Stop TB ... Global Drug Facility, has provided anti-TB drug treatments for 10 ... ,"This is an important milestone, because getting anti-TB ... complete their treatment is the only way to break the ...

... resulting from broken families continues to take a heavy toll. ... and her three children has sent shockwaves across the ... her small daughters and herself in a closet using pieces ... an 8-month-old daughter, was also found dangling in the closet ...

... the problem of separating and aligning tangled nanowires and ... nanoscale electronic components, such as transistors, a new study ... of their research, Guihua Yu and Charles Lieber of ... Hawaii, US, used nitrogen gas to blow bubbles of ...

Cached Medicine News:Health News:How to Cope With Side Effects from Pelvic Radiotherapy 2 Health News:Natural Compound in Grapes, Tea and Cocoa Helps to Enhance Memory 2 Health News:Stop TB Partnership Has Provided Treatments for Ten Million People in Six Years 2 Health News:Mother Hangs Herself and Three Children in Texas 2

How to Cope With Side Effects from Pelvic Radiotherapy Skinny Girl-bands are Making Detrimental Impact on Teenage Girls Natural Compound in Grapes, Tea and Cocoa Helps to Enhance Memory Stop TB Partnership Has Provided Treatments for Ten Million People in Six Years Mother Hangs Herself and Three Children in Texas Bubbles may Pave Way for Producing Nanoscale Electronic Components

(Date:1/15/2014)... , January 15, 2014 Shire plc ... has waived the Office of Fair Trading (OFT) approval condition ... shares of ViroPharma Incorporated (NASDAQ: VPHM). As ... conditional on OFT approval, and Shire expects to complete the ... expiration time, subject to the satisfaction of all of the ...

(Date:1/15/2014)... 15, 2014 Tegra Medical is very pleased ... King as its new Chief Executive Officer. Mark ... Officer, in which he has overseen the company,s four ... Mississippi , and Costa Rica. Mr. King joined ... operations, sales, engineering and manufacturing experience in medical device ...

(Date:1/15/2014)... , Jan. 15, 2014 ... report is available in its catalogue: ... Forecast – Worldwide Analysis ... Market Analysis Insulin ... market as insulin delivery systems especially for ...

[0] Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc.[0] Tegra Medical Appoints New Chief Executive Officer [0] Insulin Pump Market & Forecast - Worldwide Analysis

... commence shortly, CARMIEL, Israel, April 18, 2007 /PRNewswire-FirstCall/ ... received,written notice from the United States Food and ... III clinical trial in the United,States of its ... recombinant form of human Glucocerebrosidase (GCD),for the treatment ...

... Meeting Also Showed No,Significant Impact on Weight for ... --,Findings from two separate pooled analyses - one ... and the,other on painful symptoms associated with major ... pooled analysis that examined the,effect of desvenlafaxine succinate ...

Cached Medicine Technology:Protalix BioTherapeutics, Inc. Receives Approval from the FDA to,Initiate a Phase III Clinical Trial of prGCD 2 Protalix BioTherapeutics, Inc. Receives Approval from the FDA to,Initiate a Phase III Clinical Trial of prGCD 3 Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 2 Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 3 Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 4 Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 5 Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 6

Protalix BioTherapeutics, Inc. Receives Approval from the FDA to,Initiate a Phase III Clinical Trial of prGCD Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

Medicine Products:

BNP Body Fluid Culture (Includes Gram Stain 0060101)Blood Type, Prenatal Blood Grouping & RH Typing